LU67585A1 - - Google Patents

Info

Publication number
LU67585A1
LU67585A1 LU67585A LU67585DA LU67585A1 LU 67585 A1 LU67585 A1 LU 67585A1 LU 67585 A LU67585 A LU 67585A LU 67585D A LU67585D A LU 67585DA LU 67585 A1 LU67585 A1 LU 67585A1
Authority
LU
Luxembourg
Application number
LU67585A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU67585A1 publication Critical patent/LU67585A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU67585A 1972-05-12 1973-05-11 LU67585A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2248972A GB1436324A (en) 1972-05-12 1972-05-12 Anaesthetic 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
LU67585A1 true LU67585A1 (fr) 1973-07-24

Family

ID=10180241

Family Applications (1)

Application Number Title Priority Date Filing Date
LU67585A LU67585A1 (fr) 1972-05-12 1973-05-11

Country Status (13)

Country Link
US (1) US3998829A (fr)
JP (1) JPS4948652A (fr)
AU (1) AU474687B2 (fr)
BE (1) BE799433A (fr)
CA (1) CA1014947A (fr)
DE (1) DE2323950A1 (fr)
DK (1) DK135775B (fr)
FR (1) FR2184711B1 (fr)
GB (1) GB1436324A (fr)
IE (1) IE38863B1 (fr)
LU (1) LU67585A1 (fr)
NL (1) NL7306606A (fr)
ZA (1) ZA733218B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613463A (en) * 1984-11-01 1986-09-23 The Upjohn Company Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5382661A (en) * 1985-09-12 1995-01-17 The Upjohn Company Pyrazinylpiperazinyl steroids
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
JPH072555Y2 (ja) * 1991-06-03 1995-01-25 日野自動車工業株式会社 車輛の前後方向兼用ウインチ
ATE284895T1 (de) * 1995-06-06 2005-01-15 Euro Celtique Sa Neuroaktive steroide der androstan- und pregnanreihe
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
US6143737A (en) * 1995-06-23 2000-11-07 Georgetown University Progesterone analogs to reverse multidrug resistance
UA73736C2 (en) * 1999-04-29 2005-09-15 Euro Celtic S A Method for alleviating or preventing insomnia and inducing anesthesia
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
EP3572417B1 (fr) 2011-10-14 2025-12-17 Sage Therapeutics, LLC Composés de 19-nor prégnane disubstitués 3,3, compositions et leurs utilisations
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
EP2986624B1 (fr) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. Stéroïdes neuroactifs 19-nor et pour l'utilisation thérapeutique
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
KR102396328B1 (ko) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ME03809B (fr) 2014-10-16 2021-04-20 Sage Therapeutics Inc Compositions et méthodes pour traiter des troubles du snc
CN117024501A (zh) * 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
WO2016082789A1 (fr) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions et procédés pour traiter des troubles du snc
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
EP4155314A1 (fr) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et leurs utilisations
WO2018013615A1 (fr) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. Stéroïdes neuroactifs substitués en c7, c12 et c16 et méthodes d'utilisation associées
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
SG11202112391UA (en) 2019-05-31 2021-12-30 Sage Therapeutics Inc Neuroactive steroids and compositions thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1107662B (de) * 1959-07-04 1961-05-31 Merck Ag E Verfahren zur Herstellung von Mannichbasen von Steroiden bzw. von deren Saeureadditionssalzen
US3042691A (en) * 1960-05-11 1962-07-03 Pfizer & Co C 5alpha,21-dibromo-6beta-fluoro-21-methyl-pregnanes and process for making same
FR1764M (fr) * 1962-02-20 1963-04-08 Roussel Uclaf Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou viscérale.
US3201425A (en) * 1963-12-10 1965-08-17 American Cyanamid Co 20-alkoxy-delta20-21-carboxaldehydes of the pregnane series and method of preparing the same
GB1089945A (en) * 1965-09-23 1967-11-08 British Drug Houses Ltd Steroidal-6-spirocyclopropyl-4-en-3-ones
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
DE1941226A1 (de) * 1969-08-13 1971-02-18 Degussa Basisch substituierte Ketosteroide
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
GB1377609A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy-5alpha-pregnane compounds
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same

Also Published As

Publication number Publication date
FR2184711A1 (fr) 1973-12-28
DK135775C (fr) 1977-11-21
IE38863L (en) 1973-11-12
DK135775B (da) 1977-06-20
NL7306606A (fr) 1973-11-14
BE799433A (fr) 1973-11-12
FR2184711B1 (fr) 1977-01-07
CA1014947A (en) 1977-08-02
JPS4948652A (fr) 1974-05-11
ZA733218B (en) 1974-05-29
US3998829A (en) 1976-12-21
AU474687B2 (en) 1976-07-29
IE38863B1 (en) 1978-06-21
AU5561673A (en) 1974-11-14
GB1436324A (en) 1976-05-19
DE2323950A1 (de) 1973-12-13

Similar Documents

Publication Publication Date Title
JPS5143929B2 (fr)
CH580591A5 (fr)
CH580659A5 (fr)
BG18404A1 (fr)
BG18459A1 (fr)
CH580074A5 (fr)
BG18503A1 (fr)
BG18508A1 (fr)
BG18743A1 (fr)
BG19234A1 (fr)
BG19419A1 (fr)
BG19715A1 (fr)
BG19862A1 (fr)
BG20735A1 (fr)
BG21139A1 (fr)
BG21593A3 (fr)
CH1675273A4 (fr)
CH249673A4 (fr)
CH303972A4 (fr)
CH561697A5 (fr)
CH562655A5 (fr)
CH565657A5 (fr)
CH569984A5 (fr)
CH570557A5 (fr)
CH578010A5 (fr)